编号 |
产品名称 |
CAS号 |
规格 |
价格 |
|
| LC-0148 |
Calcitonin, human ≥95%
Calcitonin, human ≥95% |
21215-62-3 |
| 0.5 mg |
询价 |
| 1 mg |
询价 |
| 2.5 mg |
询价 |
|
|
| LC-0149 |
Calcitonin, salmon ≥98%
Calcitonin, salmon ≥98% |
47931-85-1 |
| 0.5 mg |
询价 |
| 1 mg |
询价 |
| 2.5 mg |
询价 |
|
|
| LC-0151 |
a-Calcitonin Gene Related Peptide, human ≥98%
a-Calcitonin Gene Related Peptide, human ≥98% |
90954-53-3 |
| 0.5 mg |
询价 |
| 1 mg |
询价 |
| 2.5 mg |
询价 |
|
|
| LC-0267 |
Carnosol ≥98%
Carnosol ≥98% |
5957-80-2 |
|
|
| LC-2468 |
b-Calcitonin Gene Related Peptide, human ≥98%
b-Calcitonin Gene Related Peptide, human ≥98% |
98824-26-1 |
|
|
| LC-2803 |
Chartreusin ≥98%
Chartreusin ≥98% |
6377-18-0 |
|
|
| LC-2845 |
Levo-Chloramphenicol ≥98%
Levo-Chloramphenicol ≥98% |
56-75-7 |
|
|
| LC-2951 |
Chlortetracycline HCl 0.91
Chlortetracycline HCl 0.91 |
64-72-2 |
|
|
| LC-2957 |
Cholesterol ≥97%
Cholesterol ≥97% |
57-88-5 |
|
|
| LC-2970 |
Chrysophanol ≥98%
Chrysophanol ≥98% |
481-74-3 |
| 10 mg |
询价 |
| 25 mg |
询价 |
| 100 mg |
询价 |
|
|
| LC-3251 |
Cinnarizine ≥98%
Cinnarizine ≥98% |
298-57-7 |
|
|
| LC-3263 |
Ciprofloxacin HCl ≥98%
Ciprofloxacin HCl ≥98% |
86393-32-0 |
|
|
| LC-3477 |
Citalopram Hydrobromide ≥98%
Citalopram Hydrobromide ≥98% |
59729-32-7 |
| 25 mg |
询价 |
| 100 mg |
询价 |
| 500 mg |
询价 |
|
|
| LC-4756 |
Cloxacillin sodium ≥98%
Cloxacillin sodium ≥98% |
7081-44-9 |
|
|
| LC-4757 |
Clozapine ≥97%
Clozapine ≥97% |
5786-21-0 |
| 25 mg |
询价 |
| 100 mg |
询价 |
| 250 mg |
询价 |
|
|
| LC-5260 |
C-type natriuretic peptide (1-22), human, porcine, rat ≥95%
C-type natriuretic peptide (1-22), human, porcine, rat ≥95% |
|
|
|
| LC-5772 |
Corticotropin Releasing Factor, human, rat ≥98%
Corticotropin Releasing Factor, human, rat ≥98% |
86784-80-7 |
| 0.5 mg |
询价 |
| 1 mg |
询价 |
| 2.5 mg |
询价 |
|
|
| LC-5773 |
Cortistatin-14 ≥95%
Cortistatin-14 ≥95% |
186901-48-4 |
| 0.5 mg |
询价 |
| 1 mg |
询价 |
| 2.5 mg |
询价 |
|
|
| LC-7692 |
CTX IV (6-12) ≥98%
CTX IV (6-12) ≥98% |
|
|
|
| LC-7693 |
[Arg3,14] CTX IV (3-14) ≥98%
[Arg3,14] CTX IV (3-14) ≥98% |
|
|
|
